The medical journal Science Translational Medicine published the results of a small study that found that an implantable, wirelessly controlled microchip-based drug delivery device developed by MicroCHIPS demonstrated similar measures of safety and therapeutic levels in blood to what is observed from standard, recommended multiple subcutaneous injections of a marketed osteoporosis drug, called...
